Cargando…
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
INTRODUCTION: Assessing the response to vaccinations is one of the diagnostic criteria for Common Variable Immune Deficiencies (CVIDs). Vaccination against SARS-CoV-2 offered the unique opportunity to analyze the immune response to a novel antigen. We identify four CVIDs phenotype clusters by the in...
Autores principales: | Piano Mortari, Eva, Pulvirenti, Federica, Marcellini, Valentina, Terreri, Sara, Salinas, Ane Fernandez, Ferrari, Simona, Di Napoli, Giulia, Guadagnolo, Daniele, Sculco, Eleonora, Albano, Christian, Guercio, Marika, Di Cecca, Stefano, Milito, Cinzia, Garzi, Giulia, Pesce, Anna Maria, Bonanni, Livia, Sinibaldi, Matilde, Bordoni, Veronica, Di Cecilia, Serena, Accordini, Silvia, Castilletti, Concetta, Agrati, Chiara, Quintarelli, Concetta, Zaffina, Salvatore, Locatelli, Franco, Carsetti, Rita, Quinti, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248522/ https://www.ncbi.nlm.nih.gov/pubmed/37304298 http://dx.doi.org/10.3389/fimmu.2023.1194225 |
Ejemplares similares
-
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2022) -
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best
por: Salinas, Ane Fernandez, et al.
Publicado: (2021) -
B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2021) -
COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS
por: Pulvirenti, Federica, et al.
Publicado: (2023) -
SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience
por: Pulvirenti, Federica, et al.
Publicado: (2023)